Form 4: Sotera Health CEO Sells Over 700K Shares

Sotera Health Co's Chairman and CEO, Michael B. Petras Jr., reported the sale of 750,000 shares of common stock at $16.45 per share, effective December 8, 2025.

Summary

• Michael B. Petras Jr., Chairman and CEO of Sotera Health Co, reported transactions involving the company's common stock.
• The transactions occurred on December 8, 2025.
• A total of 750,000 shares of Common Stock, $0.01 par value per share, were disposed of at a price of $16.45 per share.
• The sales included 315,896 shares directly owned, 394,861 shares indirectly owned by a Grantor Trust, and 39,243 shares indirectly owned by a Family Trust.
• Following these transactions, Michael B. Petras Jr. beneficially owns 552,790 shares directly and 4,819,393 shares indirectly through a Grantor Trust. The Family Trust now holds 0 shares.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: This Form 4 filing is a factual report of an insider stock transaction. While insider selling can sometimes be viewed with caution, the filing indicates the transaction was made pursuant to a Rule 10b5-1 plan, suggesting it was pre-scheduled and not necessarily indicative of a change in management's outlook. Therefore, a neutral sentiment is assigned based solely on the information provided in this regulatory filing.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal, though the transaction was executed under a Rule 10b5-1 plan, which typically pre-schedules sales to avoid accusations of trading on material non-public information.

Key Dates

Keywords

Sotera Health, SHC, Insider Trading, Form 4, Stock Sale, CEO, Michael B. Petras Jr., Common Stock, Rule 10b5-1